HOME › DRUGS › QUADRIVALENT INFLUENZA VACCINE (RECOMBINANT, PREPARED IN CELL CULTURE)
ACTIVE SUBSTANCE / INN

QUADRIVALENT INFLUENZA VACCINE (RECOMBINANT, PREPARED IN CELL CULTURE)

Brand name(s): Supemtek Tetra (previously Supemtek)
EMA LISTED
AUTHORISED
Influenza, Human
ACTIVE SUBSTANCE
Quadrivalent Influenza Vaccine (Recombinant, Prepared In Cell Culture)
REGULATORS
EMA
SPONSORS / MAH
Sanofi Winthrop Industrie
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Supemtek Tetra (previously Supemtek)Sanofi Winthrop IndustrieAuthorised16/11/2020Influenza, Human

FULL INTELLIGENCE ON QUADRIVALENT INFLUENZA VACCINE (RECOMBINANT, PREPARED IN CELL CULTURE)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →